Canadian Consortium on Neurodegeneration in Aging (CCNA)
The Canadian Consortium on Neurodegeneration in Aging (CCNA) provides the infrastructure and support that facilitates collaboration amongst Canada’s top dementia researchers.
By accelerating the discovery, innovation, and the adoption of new knowledge, the CCNA positions Canada as a global leader in increasing understanding of neurodegenerative diseases, working towards prevention, and improving the quality of life of those living with dementia.
350+ clinicians and researchers throughout Canada form the CCNA and are accelerating progress in age-related neurodegenerative diseases, including Alzheimer’s disease, Vascular dementia, Frontotemporal dementia, and Lewy body dementia. Based on their area of specialization, CCNA’s researchers are divided into 20 teams throughout Canada, and are working in the areas of prevention, treatment, and quality of life.
The CCNA’s combined expertise will be used to strengthen understanding of:
- How these diseases develop.
- Their impact on the individual, families, and the community as a whole.
- What can be done to slow their progression and cope with them, if not prevent the diseases altogether.
By doing this, the CCNA will positively impact the quality of life and the quality of services for individuals living with neurodegenerative diseases.